Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Pharmacist’s timely intervention helps to avert risk of wrong usage of inhaler

A pharmacist’s timely reporting to the Yellow Card scheme has helped the MHRA and an inhaler manufacturer to improve the safety information to avert potential risk of wrong usage of inhaler.

Jazz, a concerned pharmacist, alerted the MHRA of the potential risk of inhaler after a patient nearly choked when accidentally inhaling lung medication capsule through the wrong part of the inhaler.


Following the alert from the pharmacist, the Medicines and Healthcare products Regulatory Agency (MHRA) conducted a detailed investigation and found that there was potential for confusion when using the medicine and the device in combination.

The MHRA later worked with the manufacturer to improve the safety information.

Jazz, pharmacist and Yellow Card reporter said: “Now the products come with warnings about choking and clearer instructions on how to insert the capsule correctly into the device, including pictures that make it easy to understand.

“The MHRA also alerted doctors, pharmacists and healthcare professionals across the UK about the safety risk.

“It really goes to show that every piece of information is important and can make such a big difference to patient safety.”

Mick Foy, manager at the MHRA’s Vigilance and Risk Management of Medicines Division, said: “…The MHRA uses Yellow Card reports to strengthen our investigations and advice on how to use products safely to protect patients.

“Whether you’ve experienced a side effect, seen a faulty medical device, or observed a potential issue, your report to the Yellow Card scheme helps us take action to protect everyone.”

Anyone can use the Yellow Card scheme to report suspected side effects of medicines, incidents involving medical devices, and defective or fake medical products.

More For You

Air pollution in UK linked to thousands of deaths and chronic health conditions

A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

iStock

Royal College of Physicians paints grim picture of air pollution in UK

Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.

The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.

Keep ReadingShow less
Community pharmacies falling behind on data security toolkit submissions

The last date for submission is 30 June 2025.

Pic credit: iStock

Community pharmacies falling behind on data security toolkit submissions

More than 50 per cent of the community pharmacies in England have failed to complete their Data Security and Protection Toolkit 2025 with the deadline in less than two weeks.

Necessary guidance regarding the toolkit has previously been provided by Community Pharmacy England (CPE) earlier.

Keep ReadingShow less
Digital guide launched to help patients with osteoporosis

In the UK, over three million people have osteoporosis.

Pic credit: iStock

Digital guide launched to help patients with osteoporosis

The Royal Osteoporosis Society (ROS) has launched a free online service called BoneMed which is aimed to support patients with osteoporosis in taking their medicine and remove barriers to adherence.

After completing a five-minute online survey, patients will be emailed a summary of the medicine they have been prescribed and six further updates throughout the year on their medication.

Keep ReadingShow less
GPhC five-year plan to empower pharmacists, uphold public trust

GPhC's Strategic Plan 2025-30 will focus on empowering pharmacists and pharmacy technicians.

iStock

GPhC five-year plan to empower pharmacists, uphold public trust

The General Pharmaceutical Council (GPhC) launched its new plan for the next five years to uphold safety, quality and public trust in pharmacy.

The regulatory body unveiled its Strategic Plan 2025-30 during a Parliamentary event attended by pharmacy minister Stephen Kinnock on Wednesday (18).

Keep ReadingShow less
Glucose monitor and test strips on a blood sugar tracker sheet with lancets and pen device.

Medical device manufacturers will have to monitor the safety and performance of their products already in use.

iStock

Medical device regulation overhauled to improve patients' safety

Medical device manufacturers must now adhere to the UK's post-market surveillance (PMS) regulations.

The new rule came into effect on June 16, and manufacturers will have to monitor the safety and performance of their products already in use.

Keep ReadingShow less